Cargando…

Upregulation of PCED1B-AS1 in proliferative diabetic retinopathy and its involvement in retinal vascular endothelial cell proliferation

BACKGROUND: This study was to assess the diagnostic value of PCED1B-AS1 for proliferative diabetic retinopathy (PDR) and investigate the involvement of PCED1B-AS1 in PDR. METHODS: The vitreous and blood specimens from 37 subjects with PDR and 21 non-diabetics were examined by reverse transcription q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuyang, Chen, Wangling, Lao, Wei, Chen, Yunxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685937/ https://www.ncbi.nlm.nih.gov/pubmed/36418980 http://dx.doi.org/10.1186/s12886-022-02683-6

Ejemplares similares

Long Noncoding RNA PCED1B-AS1 Promotes the Warburg Effect and Tumorigenesis by Upregulating HIF-1α in Glioblastoma
por: Yao, Zhiqiang, et al.
Publicado: (2020)

Relationships among Retinal Nonperfusion, Neovascularization, and Vascular Endothelial Growth Factor Levels in Quiescent Proliferative Diabetic Retinopathy
por: Ra, Ho, et al.
Publicado: (2020)

Effect of pan-retinal laser photocoagulation on intravitreal vascular endothelial growth factor concentration in proliferative diabetic retinopathy
por: Nišić, Faruk, et al.
Publicado: (2022)

Increased Vitreous Shedding of Microparticles in Proliferative Diabetic Retinopathy Stimulates Endothelial Proliferation
por: Chahed, Sadri, et al.
Publicado: (2010)

Long noncoding RNA PCED1B-AS1 promotes erythroid differentiation coordinating with GATA1 and chromatin remodeling
por: Zhu, Junwei, et al.
Publicado: (2019)

Association of the Pattern of Retinal Capillary Non-Perfusion and Vascular Leakage with Retinal Neovascularization in Proliferative Diabetic Retinopathy
por: Jung, Eric E., et al.
Publicado: (2021)

Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
por: Chen, Hui-Jin, et al.
Publicado: (2019)

Long non-coding RNA PCED1B-AS1 promotes the proliferation of colorectal adenocarcinoma through regulating the miR-633/HOXA9 axis
por: Liu, Jianfeng, et al.
Publicado: (2022)

Dysregulation of miR-210 is involved in the development of diabetic retinopathy and serves a regulatory role in retinal vascular endothelial cell proliferation
por: Yin, Chengyu, et al.
Publicado: (2020)

Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy
por: Petrovič, Mojca Globočnik, et al.
Publicado: (2008)

Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
por: Zhao, Yue, et al.
Publicado: (2018)

Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
por: Wu, Lihteh, et al.
Publicado: (2019)

Limited hyperoxia-induced proliferative retinopathy: A model of persistent retinal vascular dysfunction, preretinal fibrosis and hyaloidal vascular reprogramming for retinal rescue
por: Tedeschi, Thomas, et al.
Publicado: (2022)

LncRNA PCED1B-AS1 knockdown inhibits osteosarcoma via methylation-mediated miR-10a downregulation
por: Wang, Bing, et al.
Publicado: (2022)

Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption
por: Lajko, Michelle, et al.
Publicado: (2016)

Alterations in Retinal Vascular and Oxygen Metrics in Treated and Untreated Proliferative Diabetic Retinopathy: A Case Report
por: Rahimi, Mansour, et al.
Publicado: (2022)

Clinical Features and Surgical Treatment of Subretinal Proliferation in Proliferative Diabetic Retinopathy
por: Wu, Chan, et al.
Publicado: (2022)

Anti-Vascular Endothelial Growth Factor Therapy as an Alternative or Adjunct to Pan-Retinal Photocoagulation in Treating Proliferative Diabetic Retinopathy: Meta-Analysis of Randomized Trials
por: Gao, Shuang, et al.
Publicado: (2020)

Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy
por: Gao, Xinxiao, et al.
Publicado: (2015)

Key Factors to Improve the Outcome of Retinal Reattachment Surgery in Proliferative Vitreoretinopathy and Proliferative Diabetic Retinopathy
por: Deuchler, Svenja, et al.
Publicado: (2017)

The Warburg effect alters amino acid homeostasis in human retinal endothelial cells: implication for proliferative diabetic retinopathy
por: Gregory, Andrew, et al.
Publicado: (2023)

Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis
por: Qin, Jianhua, et al.
Publicado: (2021)

Long non-coding RNA PCED1B-AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR-411-3p/HIF-1α axis
por: Zhang, Yi, et al.
Publicado: (2021)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
por: Muhiddin, Habibah Setyawati, et al.
Publicado: (2020)

Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020)

Retinal expression of small non-coding RNAs in a murine model of proliferative retinopathy
por: Liu, Chi-Hsiu, et al.
Publicado: (2016)

Diabetic macular edema and proliferative diabetic retinopathy treated with anti-vascular endothelial growth factor under the reimbursement policy in Taiwan
por: Hsieh, Ming-Chieh, et al.
Publicado: (2022)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Endothelial-to-mesenchymal transition contributes to the myofibroblast population in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M.
Publicado: (2016)

Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy
por: Baharivand, Nader, et al.
Publicado: (2012)

Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic Retinopathy
por: Gunasekaran, Thiruvarasu, et al.
Publicado: (2022)

Lymphatic Vascular Structures: A New Aspect in Proliferative Diabetic Retinopathy
por: Gucciardo, Erika, et al.
Publicado: (2018)

S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2014)

Twenty-seven-gauge vitrectomy for combined tractional and rhegmatogenous retinal detachment involving the macula associated with proliferative diabetic retinopathy
por: Cruz-Iñigo, Yousef J., et al.
Publicado: (2017)

Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
por: El-Batarny, Ashraf M
Publicado: (2007)

Proliferative diabetic retinopathy: predictive and preventive measures at hypoxia induced retinal changes
por: Josifova, Tatjana, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vu8t637sam9gp0abk906uoimig